Malignant pleural mesothelioma is a rare and lethal cancer caused by exposure to asbestos.
The highly inflammatory environment caused by fibers accumulation forces cells to undergo …

Introduction: Since there remains no effective, durable chemotherapy against malignant
pleural mesothelioma (MPM), we propose to leverage microRNA (miR)-based approaches …

We employed RNA sequencing analysis to reveal dysregulated lncRNAs in lung cancer
utilizing 461 lung adenocarcinomas and 156 normal lung tissues from 3 separate cohorts …

Malignant Pleural Mesothelioma (MPM) is an aggressive cancer that is often diagnosed at
an advanced stage and is characterized by a long latency period (20–40 years between …

Accumulating evidence has shown a critical role of long‐non‐coding RNAs (lncRNAs)
during multiple tumor progression. However, the potential functions of LINC00504 in colon …

Malignant pleural mesothelioma (MPM) is a rare but invasive cancer, which mainly arises
from mesothelial tissues of pleura, peritoneum and pericardium. Despite significant …

Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung cancer cases. The
pathogenesis of NSCLC involves complex gene networks that include different types of non …

Background: Malignant pleural mesothelioma (MPM) is an aggressive tumour originating in
the thoracic mesothelium. Prognosis remains poor with 9-to 12-month median survival, and …

Malignant pleural mesothelioma (MPM) is an incurable surface neoplasm with peculiar
pathobiology. MPM proliferates by using the tyrosine-kinase-Ras pathway. Despite …

Long non-coding RNA LINC01116 is involved in the occurrence and progression of a variety
of cancers. However, the specific role of LINC01116 in lung adenocarcinoma (LUAD) …